Wikipedia -WSS

Wikipedia

author：fashion 2025-09-29 21:15:05 - browse：571

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

“I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Akero's treatment for NASH falls short in cirrhosis study

explore

WSS

Medicare drug price negotiation hasn't dried up venture capital

In Spain, a hospital brews its own CAR

Medicare to cover more brain scans related to Alzheimer’s drugs

Why health records don't always know when patients are dead

European regulators recommend Amylyx's ALS drug be rejected

What STAT readers think about the FDA and patient advocacy

entertainment

Wikipedia

knowledge

Jerome Adams on the need for new antivirals for Covid

There’s no way to know how good AI health technologies are

Virginia high school admissions case could be legal follow

David Ricks of Eli Lilly: best biopharma CEO of 2023

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Cancer drug shortages should be causing more outrage

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Medical leaders decry Supreme Court decision on affirmative action

Life sciences deals on track to hit lowest point since 2017

focus

What STAT readers think about the FDA and patient advocacy

Prime Medicine, Myeloid Therapeutics clash over genome

Nick Jonas talks about managing diabetes along with his career

Better Therapeutics data on benefit with GLP

European regulators consider appeal over Amylyx ALS drug

Drinking less cuts risk of oral cavity, esophageal cancer: Report

hotspot

explore

knowledge

entertainment